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Abstract The aim of this work was to compare the
effects on human amniotic membrane of freeze-drying
and c-irradiation at doses of 10, 20 and 30 kGy, with
freezing. For this purpose, nine cytokines (interleukin
10, platelet-derived growth factor-AA, platelet-
derived growth factor-BB, basic fibroblast growth
factor, epidermal growth factor, transforming growth
factor beta 1, and tissue inhibitors of metallopro-
teinase-1, -2, and -4) were titrated in 5 different
preparations for each of 3 amniotic membranes
included in the study. In addition, the extracellular
matrix structure of each sample was assessed by
transmission electron microscopy. While freeze-dry-
ing did not seem to affect the biological structure or
cytokine content of the different amniotic membrane
samples, c-irradiation led to a significant decrease in
the tissue inhibitors of metalloproteinase-4, basic
fibroblast growth factor and epidermal growth factor,
and induced structural damage to the epithelium,
basement membrane and lamina densa. The higher the
irradiation dose the more severe the damage to the
amniotic membrane structure. In conclusion, the
Authors recommend processing amniotic membrane
under sterile conditions to guarantee safety at every
step rather than final sterilization with c-irradiation,
thereby avoiding alteration to the biological charac-
teristics of the amniotic membrane.
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Introduction
Human amniotic membrane (HAM) has been used in a
variety of surgical procedures. First employed in skin
transplantation by (Davis 1910), HAM was subse-
quently found to be useful as a biological wound
dressing for burns (Ramakrishnan and Jayaraman
1997; Branski et al. 2008), acute (Tekin et al. 2008)
and chronic wounds (Gajiwala and Lobo 2003;
Insausti et al. 2010), and in the reconstruction of the
dura mater (Tomita et al. 2012; De Weerd et al. 2013),
oral cavity (Lawson 1985), vaginal vault (Ashworth
et al. 1986), tendons (Ozbo¨lu¨k et al. 2010) and nerves
(O’Neill et al. 2009). HAM has also long been used in
ophthalmic surgery, the earliest reported application
being in 1940 when De Ro¨tth used fetal membranes to
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correct symblepharon (De Ro¨tth 1940). Today HAM
is widely used for ocular surface reconstruction and
treating several important ocular diseases (Paolin et al.
2016). All these applications are possible because
HAM has anti-inflammatory, antifibrotic properties
(Solomon et al. 2001; Tseng et al. 1999).
Hao et al. have shown that human amniotic
epithelial and mesenchymal cells both express inter-
leukin-1 receptor antagonist, all the four tissue
inhibitors of metalloproteinase (TIMPs), collagen
XVIII, and interleukin-10 (Hao 2000). Moreover,
reverse transcriptase–polymerase chain reaction (RT-
PCR) has shown that HAM expresses several addi-
tional cytokines, such as transforming growth factor
(TGF-a, -b1, -b2), epidermal growth factor (EGF),
keratinocyte growth factor (KGF), basic fibroblast
growth factor (bFGF), keratinocyte growth factor
receptor (KGFR), hepatocyte growth factor (HGF) and
hepatocyte growth factor receptor (HGFR) (Koizumi
et al. 2000; Li et al. 2005; Gicquel et al. 2009).
Since these factors may contribute to the clinical
outcomes of HAM implants, several studies have
endeavored to evaluate the effects of HAM storage
conditions on their content and cell viability (Henner-
bichler et al. 2007, Wolbank et al. 2009).
To date, the methods adopted for HAM storage are
freezing at -80 C (Mermet et al. 2007) or at
-196 C in liquid nitrogen vapor (Alio´ et al. 2005),
and freeze-drying (Rahman et al. 2009; Riau et al.
2010).
In 2001, Adds et al. reported no differences in terms
of clinical results between fresh and frozen HAM, both
preparations resulting in improved visual acuity.
Furthermore, fresh tissue performed no better than
frozen tissue in promoting re-epithelialization (Adds
et al. 2001). It has, however, been demonstrated that
different processing, storage and sterilization methods
do affect HAM properties. (von Versen-Ho¨ynck et al.
2004).
Rodriguez-Ares et al. studied the effects of freeze-
drying and cryopreservation on HAM histological
characteristics and protein levels. The authors found
that although lyophilization does not affect the
histological structure of HAM, it seems to reduce
growth factor concentration more than cryopreserva-
tion (Rodriguez-Ares et al. 2009). Ricci et al. demon-
strated that cryopreservation maintains the anti-
fibrotic properties of HAM when used as a patch to
reduce the severity of liver fibrosis (Ricci et al. 2013).
Freeze-dried HAM does, however, have the advantage
of allowing storage and shipment at room temperature,
making handling much easier.
The aim of this study was to evaluate the effect of c-
irradiation on cytokine levels and the ultrastructure of
the extracellular matrix of different HAM
preparations.
Accordingly, we a) carried out a quantitative
measurement of the following cytokines: interleukin
10 (IL-10), platelet-derived growth factor-AA (PDGF-
AA), platelet-derived growth factor-BB (PDGF-BB),
basic fibroblast growth factor (bFGF), epidermal
growth factor (EGF), transforming growth factor beta
1 (TGF-b1), tissue inhibitors of metalloproteinase-1
(TIMP-1), -2 (TIMP-2), and -4 (TIMP-4), and b)
analyzed each HAM preparation with transmission
electron microscopy.
Materials and methods
HAM collection and processing
Three placentas were sourced from elective cesarean
sections after obtaining written informed consent in
hospitals belonging to our tissue bank procurement
network. Donors were selected on the basis of strict
criteria that also include guidelines for harvesting,
processing and distributing tissues for transplantation
as approved by the National Transplant Centre.
Selection criteria included the absence of any kind
of malignancy, infant malformation or pathology, a
gestation period of at least 35 weeks, negative family
medical history for genetic diseases, and lifestyles of
both parents not at risk for infectious diseases. On
arrival at the bank the tissues were anonymized with a
unique code number used for all processing phases.
Working in sterile conditions in a laminar flow
cabinet within 24 h of tissue retrieval, HAM was
carefully detached from the chorion and rinsed with
saline solution to remove blood clots.
After processing, HAM underwent microbiological
testing to ascertain its sterility and was frozen at -
80 C without cryprotectant. Prior to the study the
HAM specimens were thawed, rinsed in saline solu-
tion and sterile water. Each HAM specimen was cut
into 5 samples referred to as follows: a) ‘‘fresh-
frozen’’ (one sample): left unprocessed, b) ‘‘freeze-
dried’’ (one sample): freeze-dried, and c) ‘‘c-
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irradiated’’ (3 samples): freeze-dried and sterilized
with c-irradiation at doses of 10, 20 and 30 kGy
respectively.
The study design was not submitted to our ethical
committee as consent had already been given for both
clinical and research purposes.
Cytokine quantitative assessment
A specific enzyme-linked immunosorbent assay
(ELISA) kit (R&D Human Immunoassay) was used
for each cytokine, as shown in Table 1.
The assay employs the quantitative sandwich
enzyme immunoassay technique whereby an antibody
specific for each cytokine is pre-coated onto a
microplate. The analysis was performed twice for
each cytokine, in triplicate. Samples were re-sus-
pended in Triton X-100 lysis buffer (20 mM Hepes,
pH 7.4, 150 mM NaCl, 10 % glycerol, 1 % Triton
X-100, and Complete Protease Inhibitor mixture) and
placed on ice for 30 min, after which, the extracts were
centrifuged for 30 min at 14,000 9 g at 4 C to
remove debris before performing the ELISA assays.
The ELISA assays were performed in compliance with
the manufacturer’s instructions. The total protein
content of each sample was determined by the
Bradford protein assay and used to normalize the total
cytokine concentration.
Microscopic and ultrastructural analysis
Small formalin-fixed HAM samples were embedded
in paraffin and stained with Hematoxylin-Eosin
(Orlandi et al. 2005). For transmission electron
microscopy, small reconstituted samples were fixed
overnight in Karnovsky fixative containing 2 %
glutaraldehyde, 2 % paraformaldehyde in 0.1 M
sodium cacodylate buffer (pH 7.4), post-fixed in 1 %
OsO4 for 2 h and dehydrated through an alcohol series
and propylene oxide before embedding in EPON 812,
as reported (Spagnoli et al. 1995). Ultrathin sections
were cut with an 8800 ultramicrotome III (LKB,
Bromma, Sweden), counterstained with uranyl acetate
and lead citrate, and studied under a Hitachi electron
microscope.
Statistical analysis
Student’s t test was used to compare the different
cytokine levels present in the different HAM prepa-
rations. Statistical significance was set at p\ 0.05.
Results
Quantitative cytokine measurements
The numerical content of cytokines in pg/mg for each
HAM preparation and their percentage variations
versus fresh-frozen samples are shown in Table 2.
Figure 1 presents these data in histogram form.
Compared to fresh-frozen samples, TIMP-1 and
TIMP-2 levels were not significantly affected either by
freeze-drying or irradiation, even though the 30 kGy
c-irradiated HAMs showed a 22 % fall in TIMP-1 and
a 35 % decrease for TIMP-2 levels. Moreover, the fall
Table 1 Assay kit used for each cytokine analysis
Cytokine ELISA kit
IL-10 Quantikine ELISA–human IL-10 immunoassay, R&D catalog number D1000B
PDGF-BB Quantikine ELISA human PDGF-BB immunoassay, R&D catalog number DBB00
PDGF-AA Quantikine ELISA human/mouse PDGF-AA immunoassay, R&D catalog number DAA00B
bFGF Quantikine ELISA human FGF basic immunoassay, R&D catalog number DFB50
TGF-b1 Quantikine ELISA human TGF-b1 immunoassay, R&D catalog number DB100B
TIMP-1 Quantikine ELISA human TIMP-1 immunoassay, R&D catalog number DTM100
TIMP-2 Quantikine ELISA human TIMP-2 immunoassay, R&D catalog number DTM200
TIMP-4 Quantikine ELISA human TIMP-4 immunoassay, R&D catalog number DTM400
EGF Quantikine ELISA human EGF immunoassay, R&D catalog number DEG00
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in TIMP-1 content was observed in only one of the
three samples and was not statistically significant.
Compared to fresh-frozen HAM, TIMP-4 was signif-
icantly lower (-66 %) in 10 kGy-irradiated HAM
samples (p\ 0.05*), and in 20 and 30 kGy irradiated
HAMs (p\ 0.01**; -74 and -81 % respectively).
The highest c-irradiation dose caused a 69 %,
statistically significant, decrease in bFGF (p\ 0.05*)
Table 2 Cytokine concentrations in the different preparations
Preparation Cytokine concentration (pg/mg)
TIMP-1 TIMP-2 TIMP-4 bFGF PDGF-AA PDGF-BB EGF IL-10 TFG-b1















































































Percentage changes in cytokine content compared to fresh-frozen samples given in brackets
Fig. 1 Cytokine concentrations. Cytokine concentrations in different preparations of HAM samples: fresh-frozen, freeze-dried, and
sterilized with 10–20–30 kGy c-irradiation. * indicates p\ 0.05, ** indicates p\ 0.01
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versus fresh-frozen samples, whereas low-dose irra-
diation and freeze-drying did not significantly affect
bFGF content in any HAM preparation.
EGF levels fell significantly by 57 and 76 %
respectively following 20 kGy (p\ 0.05*) and
30 kGy (p\ 0.01**) irradiation, in contrast to the
lowest-dose irradiation and freeze-drying, which did
not significantly affect EGF levels compared to fresh-
frozen samples.
Compared to the fresh-frozen samples, PDGF-AA
and PDGF-BB levels were not significantly affected
by either freeze-drying or irradiation, even if 30 kGy
c-irradiated HAM samples were found to have 65 %
less PDGF-AA and 23 % less PDGF-BB compared to
the fresh-frozen samples.
Lastly, IL-10 and TGFb-1 concentrations were not
significantly affected either by irradiation or freeze-
drying in any samples.
Ultrastructural analysis and HAM damage
Figure 2 shows representative ultrastructural images
of different HAM samples. The transmission electron
microscopy images in Fig. 2a–c show fresh-frozen
HAM samples to have well-preserved epithelium,
with the presence of apical microvilli, cytoplasmic
vacuoles and basement membrane. Electrondense
structures and hemidesmosomes are also visible. The
collagen matrix morphology of the basal lamina is also
fairly well preserved. In the images Fig. 2d–f, taken
after freeze-drying, the epithelium, microvilli, vac-
uoles, electron-dense structures, basement membrane,
and hemidesmosomes are still visible. Nuclear
changes can be seen while the collagen matrix
morphology of the basal lamina is largely preserved.
One sample (Fig. 2d) shows more severe tissue
damage, with the epithelium and basement membrane
no longer visible. Samples exposed to 10 kGy irradi-
ation (Fig. 2g–i) display surface epithelium with loss
of microvilli, intracytoplasmic vacuoles, electron-
dense structures and nuclear degenerative changes.
The basement membrane also appears thinner and
there are fewer hemidesmosomes. However, the
collagen matrix of the lamina densa is preserved. In
one sample (Fig. 2g), the changes are more severe: no
epithelium or basement membrane is visible and the
collagen matrix of the lamina densa is degenerated and
markedly disrupted. The three images of samples
Fig. 2 Ultrastructure evaluation of differently prepared HAM samples: a, b, c fresh-frozen HAM, d, e, f freeze-dried HAM, g, h,
i freeze-dried HAM, 10 kGy irradiated, l, m, n freeze-dried HAM, 20 kGy irradiated, o, p, q freeze-dried HAM, 30 kGy irradiated
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exposed to 20 kGy irradiation (Fig. 2l–n) evidence no
epithelium or basement membrane in two of the three
specimens. The collagen matrix of the lamina densa is
poorly preserved and almost degenerated. In the image
of the third 20 kGy-irradiated sample (Fig. 2m), the
epithelium, cytoplasmic vacuoles and electron-dense
structures are partially preserved, but degenerative
nuclear changes can be observed. However, the
basement membrane and hemidesmosomes are pre-
served. 2 of the 3 samples exposed to 30 kGy
irradiation (Fig. 2o–q) show no epithelium or base-
ment membrane, whereas one sample evidences only a
thinning of these structures; the collagen matrix of the
lamina densa is, however, thinner and abnormal.
Almost complete homogenization of the cell surface
layer can be seen in two examples.
Discussion
Our findings show that all the cytokines analyzed were
present in fresh-frozen samples and were still present
after freeze-drying, whereas sterilization of HAM by
exposure to c-radiation led to significant cytokine
losses. Moreover, sterilization by c-irradiation pro-
portionally affected the ECM ultrastructure, indicative
that the higher the irradiation dose, the more severe the
ECM damage.
The cytokines analyzed in this study are among
those most frequently indicated in the literature as
involved in wound healing and tissue regeneration
processes.
TIMP-1, -2 and -4 are inhibitors of matrix metal-
loproteinases (MMPs), a group of peptidases involved
in degradation of the ECM. In addition to their
inhibitory role, TIMPs promote cell proliferation in a
wide range of cell types, and may also have an anti-
apoptotic function. Basic FGF is a potent angiogenic
factor and an endothelial cell mitogen, and has been
described as a multipotent cytokine regulating cell
growth and differentiation, matrix composition,
chemotaxis, cell adhesion and migration in a variety
of cell types (Makino et al. 2010). bFGF is known to
stimulate proliferation of cultured fibroblasts.
Members of the PDGF family are mitogenic factors
for cells of mesenchymal origin. PDGF-BB modulates
endothelial proliferation and angiogenesis (Battegay
et al. 1994), while IL-10, secreted bymacrophages and
mast cells, is an important immunoregulatory cytokine
with anti-inflammatory effects. IL-10 is also released
by cytotoxic T cells to inhibit viral infection (Khan
2008). TGF-b1 and EGF both play an important role in
the growth, proliferation and differentiation of numer-
ous cell types. In particular, EGF is a potent mitogen
for epithelial cell growth, promoting wound healing
following transplantation (Koizumi et al. 2000).
Our results showed the various TIMPs to have
differing sensitivity to gamma-irradiation. This may
be due to several reasons, including, for example,
being part of a protein complex, which reduces the
likelihood of being affected by radiation. The different
amino acid content of the three proteins may also
contribute to determining sensitivity to radiation. In
this regard, one of the main targets of radiation is the
amino acid tyrosine. Interestingly, TIMP-4 contains
twice as much tyrosine as TIMP-1 and -2, which may
explain why TIPM-4 is more sensitive to radiation
treatment than TIMP-1/-2. It is also possible, however,
that gamma irradiation directly affects the immuno-
genic structure of TIMP-4 and EGF, disrupting
specific epitope(s) recognized by the antibodies used
in the ELISA Kit. A similar effect may also be present
in other cytokines. However, if the affected epi-
tope(s) is not recognized by the kit antibodies, no
difference in protein content will detected. It should
also be noted that the experiments conducted were
confined to detecting the presence of the proteins and
not their biological function. Differences in the
observed concentration of the various TIMPs might
not reflect actual biological activity. The same
hypothesis also applies to the other cytokines, such
as EGF, whose levels fell significantly following
radiation treatment.
While the literature reports many studies describing
HAM composition after different preservation proce-
dures, the many differences in HAM harvesting and
processing methods make comparisons almost impos-
sible. Hao et al. demonstrated that HAM epithelial and
mesenchymal cells cryopreserved in glycerol at
-80 C express interleukin-1 receptor antagonist, all
four TIMPs, collagen XVIII, and interleukin-10 (Hao
2000). Other authors used the same preservation
method and found HAM to contain EGF, TGFa,
KGH, HGF, bFGF, TGF-b1, and -b2 (Li et al. 2005).
Another paper analyzed EGF, HGF, FGF, and TGF-b1
content in a tissue-suspension obtained from frozen,
freeze-dried, powdered and c-irradiated HAM, report-
ing that the freeze-drying process causes a reduction in
404 Cell Tissue Bank (2016) 17:399–406
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total protein compared to freezing alone, while
powdering causes a significantly increased release of
EGF (Russo et al. 2012). Lim et al. compared
decellularized and dehydrated human amniotic mem-
brane with cryopreserved human amniotic membrane,
and reported significant differences in the composition
and ultrastructure of dehydrated HAM as shown by
histological and immunohistochemical examination
(Lim et al. 2010). Nakamura et al. reported no
statistically significant differences in the physical
strength of cryopreserved HAM or freeze-dried HAM
treated with c-irradiation. The authors also observed
no significant alterations in tissue structure or ECM
components (Nakamura et al. 2004).
Ultrastructural analysis provided additional evi-
dence of the damage caused by c-rays, in contrast to
the absence of any severe damage evidenced in fresh-
frozen and freeze-dried samples. c-irradiation induced
major damage to the epithelium, basement membrane
and lamina densa, which was more severe after
exposure to 20 and 30 kGy c-irradiation.
Preservation of the epithelium structure is of major
importance since epithelial cells express key anti-
inflammatory factors as reported by Hao (2000).
Exposure to c-radiation is known to induce cellular
and sub-cellular damage. Radiation has a direct effect,
interacting with the structures of the target to cause
ionization and subsequent biological changes (Valen-
tin 2005; Lehnert 2007) and also an indirect action,
that can lead to the production of Reactive Oxygen
Species (ROS), which in turn, may induce important
membrane changes and cellular injury, with an
increase in polarization at higher radiation doses
([3 kGy; Mishra 2004).
In 2014, Hamid et al. demonstrated changes to the
cell morphology of glycerol-preserved amnion
exposed to 35 kGy, while air-dried HAM underwent
changes at 25 kGy. and concluded, that cell structure
preservation of glycerol-preserved amnion after radi-
ation is probably due to the radio-protectant properties
of glycerol, which removes water and limits the
formation of free radicals (Ab Hamid et al. 2014).
In our study, we observed that c-radiation causes
important changes in the amniotic epithelium, basal
lamina and basement membrane. In addition, we
detected the loss of important cytokines necessary to
promote wound healing and epithelialization, inhibit
fibrosis and scarring, and regulate angiogenesis. In
contrast, we also demonstrated that cytokine levels
and the amniotic structure-key features responsible for
the favorable clinical outcomes obtained with HAM-
were well preserved only in fresh-frozen and freeze-
dried HAM samples.
In conclusion, processing the amniotic membrane
under sterile conditions to guarantee safety at every
step as an alternative to final sterilization with c-
irradiation is strongly recommended in order to avoid
alteration of the biological characteristics of the
amniotic membrane.
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